Survival rates in kidney cancer have improved little over time, and diabetes may be an independent risk factor for poor survival in kidney cancer. We sought to determine whether medications with putative anti-neoplastic properties (statins, metformin and non-steroidal anti-inflammatory drugs (NSAIDs)...
Most survival rates for cancer are calculated by what percentage of patients are still alive after five years. For some cancers, particularly those with a high survival rate, this may be calculated based on the patients' survival for ten years. ...
The improvement in cancer survival rates could be attributed to China's major healthcare reforms and technological advances which enabled earlier diagnosis, more effective treatment, and better cancer care management, said the report. The study also found that eight types of cancer, including thyroid,...
A combination ofKeytruda(pembrolizumab) andLenvima(lenvatinib) worked better than standardSutent(sunitinib) in improving survival outcomes among adults with untreated advancedrenal cell carcinoma(RCC) — the most common type of kidney cancer in adults — ...
The aim of treating childhood cancer remains to cure all. As survival rates improve, long-term health outcomes increasingly define quality of care. The International Childhood Cancer Outcome Project developed a set of core outcomes for most types of chil
Childhood cancer is relatively rare, but there is a very good chance of cure. While overall survival rates of >70% are reported from developed countries, survival is much less likely in developing countries and unknown in many countries in Africa. Objective. To analyse survival rates of ...
Accordingly, kidney donors have survival rates the same as that of the general population and have no higher risk for developing hypertension, diabetes, end-stage renal disease and cancer. Considerations on the study is provided, which uses 255 selected donors for evaluation including for the ...
Studies have shown that survival rates are lower for African-Americans with kidney cancer compared with whites, independent of age, sex,tumorstage, and other variables. A study published in the journalCancerin 2013 found a more than four percentage point difference in the five-year survival rate...
more likely to be cancer-free a year after therapy than those who took a placebo drug, and the benefit persisted for those with mutations in their TP53 gene. The findings may present a new treatment option for a group of patients whose survival rates have not improved in more than 30 ...
Long-term survival of cancer patients in Germany achieved by the beginning of the third millenium BACKGROUND: Over the last decades, long-term survival rates have substantially increased for many forms of cancer. However, these improvements have often b... Brenner,H. - 《Annals of Oncology》 ...